| 000 | 00892 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250511171540.0 | ||
| 264 | 0 | _c19750707 | |
| 008 | 197507s 0 0 eng d | ||
| 022 | _a0098-7484 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoss, J M | |
| 245 | 0 | 0 |
_aLetter: The UGDP scandal and cover-up. _h[electronic resource] |
| 260 |
_bJAMA _cMay 1975 |
||
| 300 |
_a806-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xmortality |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xdrug therapy |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aTolbutamide _xadverse effects |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 773 | 0 |
_tJAMA _gvol. 232 _gno. 8 _gp. 806-8 |
|
| 999 |
_c1179845 _d1179845 |
||